Building on 50 years of levodopa therapy.

Suppr

超能文献

出版信息

Lancet Neurol. 2016 Jan;15(1):1. doi: 10.1016/S1474-4422(15)00349-X. Epub 2015 Dec 8.

DOI:10.1016/S1474-4422(15)00349-X

PMID:26700892

Abstract

摘要

相似文献

Building on 50 years of levodopa therapy.

Lancet Neurol. 2016 Jan;15(1):1. doi: 10.1016/S1474-4422(15)00349-X. Epub 2015 Dec 8.

[Treatment of Parkinson patients].

Praxis (Bern 1994). 2001 Jun 7;90(23):1007.

[Parkinson disease].

Praxis (Bern 1994). 2001 Jun 7;90(23):1041-6.

The natural history of treated PD in an incident, community-based cohort: does the future begin?

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1065. doi: 10.1136/jnnp.2011.246835. Epub 2011 Jul 5.

Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough.

Neurology. 2008 Aug 12;71(7):470-1. doi: 10.1212/01.wnl.0000324860.70391.25.

Levodopa-carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: first documented case.

Parkinsonism Relat Disord. 2014 Nov;20(11):1317-8. doi: 10.1016/j.parkreldis.2014.09.018. Epub 2014 Sep 17.

Parkinson's disease.

Clin Evid. 2002 Jun(7):1208-20.

Off and on state assessment of swallowing function in Parkinson's disease.

Parkinsonism Relat Disord. 2014 Sep;20(9):1033-4. doi: 10.1016/j.parkreldis.2014.06.016. Epub 2014 Jun 25.

Levodopa: 50 years of a revolutionary drug for Parkinson disease.

Mov Disord. 2015 Jan;30(1):1-3. doi: 10.1002/mds.26122. Epub 2014 Dec 8.

50 years of levodopa.

Mov Disord. 2015 Jun;30(7):1008. doi: 10.1002/mds.26240. Epub 2015 May 21.

引用本文的文献

Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway.

Front Cell Infect Microbiol. 2023 Dec 15;13:1296713. doi: 10.3389/fcimb.2023.1296713. eCollection 2023.

Translational molecular imaging and drug development in Parkinson's disease.

Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z.

Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):30-42. doi: 10.5056/jnm17105.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Building on 50 years of levodopa therapy.

Lancet Neurol. 2016 Jan;15(1):1. doi: 10.1016/S1474-4422(15)00349-X. Epub 2015 Dec 8.

[Treatment of Parkinson patients].

Praxis (Bern 1994). 2001 Jun 7;90(23):1007.

[Parkinson disease].

Praxis (Bern 1994). 2001 Jun 7;90(23):1041-6.

The natural history of treated PD in an incident, community-based cohort: does the future begin?

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1065. doi: 10.1136/jnnp.2011.246835. Epub 2011 Jul 5.

Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough.

Neurology. 2008 Aug 12;71(7):470-1. doi: 10.1212/01.wnl.0000324860.70391.25.

Levodopa-carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: first documented case.

Parkinsonism Relat Disord. 2014 Nov;20(11):1317-8. doi: 10.1016/j.parkreldis.2014.09.018. Epub 2014 Sep 17.

Parkinson's disease.

Clin Evid. 2002 Jun(7):1208-20.

Off and on state assessment of swallowing function in Parkinson's disease.

Parkinsonism Relat Disord. 2014 Sep;20(9):1033-4. doi: 10.1016/j.parkreldis.2014.06.016. Epub 2014 Jun 25.

Levodopa: 50 years of a revolutionary drug for Parkinson disease.

Mov Disord. 2015 Jan;30(1):1-3. doi: 10.1002/mds.26122. Epub 2014 Dec 8.

50 years of levodopa.

Mov Disord. 2015 Jun;30(7):1008. doi: 10.1002/mds.26240. Epub 2015 May 21.

引用本文的文献

Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway.

Front Cell Infect Microbiol. 2023 Dec 15;13:1296713. doi: 10.3389/fcimb.2023.1296713. eCollection 2023.

Translational molecular imaging and drug development in Parkinson's disease.

Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z.

Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):30-42. doi: 10.5056/jnm17105.